Traphagen Investment Advisors LLC Abbott Laboratories Transaction History

Traphagen Investment Advisors LLC

  • $868 Million
  • Q3 2024

A detailed history of Traphagen Investment Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Traphagen Investment Advisors LLC holds 4,317 shares of ABT stock, worth $489,072. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,317
Previous 4,307 0.23%
Holding current value
$489,072
Previous $447,000 10.07%
% of portfolio
0.06%
Previous 0.06%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024
BUY
$100.07 - $118.13 $1,000 - $1,181
10 Added 0.23%
4,317 $492,000
Q2 2024

Jul 23, 2024
SELL
$100.73 - $112.44 $2,618 - $2,923
-26 Reduced 0.6%
4,307 $447,000
Q1 2024

May 15, 2024
BUY
$109.52 - $120.96 $474,550 - $524,119
4,333 New
4,333 $492 Million
Q4 2023

Jun 17, 2024
SELL
$90.19 - $110.4 $992 - $1,214
-11 Reduced 0.25%
4,322 $476 Million
Q3 2023

Jun 17, 2024
BUY
$95.53 - $114.62 $93,810 - $112,556
982 Added 22.66%
5,315 $515 Million
Q2 2023

Jun 17, 2024
BUY
$100.78 - $112.29 $74,375 - $82,870
738 Added 17.03%
5,071 $553 Million
Q1 2023

Jun 17, 2024
BUY
$96.86 - $114.01 $6,973 - $8,208
72 Added 3.43%
2,170 $220 Million
Q4 2022

Jun 17, 2024
SELL
$95.06 - $111.52 $212,459 - $249,247
-2,235 Reduced 51.58%
2,098 $230 Million
Q3 2022

Jun 17, 2024
SELL
$96.76 - $112.03 $203,776 - $235,935
-2,106 Reduced 32.08%
4,459 $598 Million
Q2 2022

Jun 17, 2024
BUY
$102.07 - $123.37 $227,820 - $275,361
2,232 Added 51.51%
6,565 $915 Million
Q1 2022

Jun 17, 2024
BUY
$114.02 - $139.04 $491,198 - $598,984
4,308 Added 204.75%
6,412 $951 Million
Q4 2021

Jun 17, 2024
SELL
$115.53 - $141.46 $257,516 - $315,314
-2,229 Reduced 51.44%
2,104 $296 Million
Q3 2021

Jun 17, 2024
BUY
$116.66 - $129.06 $116 - $129
1 Added 0.05%
2,104 $249 Million
Q1 2021

Jun 17, 2024
SELL
$108.84 - $128.23 $242,713 - $285,952
-2,230 Reduced 51.47%
2,103 $252 Million
Q4 2020

Jun 17, 2024
SELL
$105.0 - $114.42 $1,785 - $1,945
-17 Reduced 0.86%
1,953 $214 Million
Q3 2020

Jun 17, 2024
SELL
$91.64 - $111.29 $216,545 - $262,978
-2,363 Reduced 54.53%
1,970 $214 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Traphagen Investment Advisors LLC Portfolio

Follow Traphagen Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traphagen Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Traphagen Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email